Challenge
A fast-growing pre-commercial biotech preparing for its first commercial launch lacked a structured quality framework, exposing it to regulatory risk and operational inconsistency.
Approach
Scimitar conducted a rapid-response diagnostic to map existing controls, prioritize documentation needs, and design a fit-for-purpose QMS. More than 65 SOPs, training modules, and governance tools were developed to align with pipeline milestones and organizational scale.
Impact
Within four months, the biotech achieved full inspection readiness and successfully passed mock audits without findings. The QMS became a scalable foundation for future filings and launches.